Clinical outcomes of exenatide versus basal insulin

Trial Identifier:	D5551R00010
Sponsor:	AstraZeneca
NCTID::	NCT02987348
Start Date:	June 2015
Primary Completion Date:	June 2015
Study Completion Date:	June 2015
Condition:	Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
UK	Cardiff, UK, CF14 3QZ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.